WHC is still in active development. Read this to understand our approach.
depiction of QHMBSVQNZZTUGM-UHFFFAOYSA-N.svg
psychonaut

Cannabidiol

Verificar en psychonaut

isomerdesign

CBD

Verificar en isomerdesign

isomerdesign

(+)-CBD

Verificar en isomerdesign

isomerdesign

epi-CBD

Verificar en isomerdesign

drugmap

Cannabidiol

Verificar en drugmap

wiki

Cannabidiol

Verificar en wiki

Data

InChI: InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3

Sinónimos: DB09061,(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,6-diol,CANNABIDIOL SOLUTION [USP-RS],CANNABIDIOL [ORANGE BOOK],Cannabidiol solution, ~10 mg/mL in ethanol, analytical standard, for drug analysis,(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-2,6-diol,1,3-benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, Epidiolex,(-)-Cannabidiol (CBD),Delta(1(2))-trans-cannabidiol,13956-29-1,CANNABIDIOL [INN],Cannabidiol solution,GWP-42003, (-)-Cannabidiol, 13956-29-1,2-[(1R,6R)-3-methyl-6-prop-1-en-2-yl-1-cyclohex-2-enyl]-5-pentylbenzene-1,3-diol,ZINC4097406,Cannabidiol [USAN],19GBJ60SN5,BDBM50121429,CARDIOLRX,2-((1R,6R)-3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-2-EN-1-YL)-5-PENTYLBENZENE-1,3-DIOL,CANNABIDIOL [INCI],2-((1R,6R)-6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol,delta1(2)-trans-Cannabidiol,2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol, delta1(2)-trans-Cannabidiol,Sativex (CBD + THC, fixed-dose oral spray),SCHEMBL119679,AC-34022,(-)-Cannabidiol (Synthetic),DB-093531,cannabidiolum,1,3-Benzenediol, 2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, (1R-trans)-,(-)-trans-Cannabidiol,UNII-19GBJ60SN5,Q422917,epi-CBD,D10915, (-)-trans-Cannabidiol,CHEMBL190461,(+)-CBD,HB2785,CHEBI:69478,CANNABIDIOL [MART.],2-(4-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol trans-,NCGC00386518-01,2-[3-Methyl-6-(methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol,Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, trans-(-)- (8CI),Cannabidiol (USAN/INN),C21H30O2,Cannabidiol (7CI),2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol,2-(6-Isopropenyl-3-methyl-2-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol #,2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol,(-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol, (-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol,BDBM50318484,DTXSID301038839,nabiximols (CBD + THC, fixed-dose oral spray),P0T,(-)-Cannabidiol,AKOS032948358,Cannabidiol,CANNABIDIOL [USP-RS],cannabidiol,.delta.1(2)-trans-Cannabidiol,CANNABIDIOL [MI],Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, (+-)-,GTPL4150,BTX-1503,2-((1R,6R)-3-METHYL-6-(1-METHYLETHENYL)CYCLOHEX-2-ENYL)-5-PENTYLBENZENE-1,3-DIOL,DTXSID00871959, UNII-19GBJ60SN5,ZYN002,Cannabidiol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,Cannabidiol solution, 1.0 mg/mL in methanol, analytical standard, for drug analysis, GWP42003-P,2-(3-methyl-6-prop-1-en-2-yl-1-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol,C07578,2-(6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol (Cannabidiol), 19GBJ60SN5,(-)-Cannabidiol 1.0 mg/ml in Methanol,CANNABIDIOL [WHO-DD],(3R,4R)-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol,GWP-42003-P,GWP42003,(+/-)-Cannabidiol, CBD,(-)-CBD,(-)-Cannabidiol (CBD) 250 microg/mL in Acetonitrile,3556-78-3,BTX-1204,1,3-BENZENEDIOL, 2-((1R,6R)-3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL)-5-PENTYL-,CBD,GWP42003-P,Epidiolex, (-)-CBD,Epidiolex (TN),(-)-Cannabidiol (CBD) 1000 microg/mL in Methanol,Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, (-)-(E)-,(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydrobiphenyl-2,6-diol,1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-,D1(2)-trans-Cannabidiol,1,3-Benzenediol, 2-(4-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, trans-,2-(6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol,(-)-Cannabidiol (CBD) 100 microg/mL in Methanol, QHMBSVQNZZTUGM-ZWKOTPCHSA-N

Market name: cbd

Estimated data

Solubilidad: -5.755 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 83.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.